syntheticbiologics.com

synthetic biologics - home

Protecting the microbiome while targeting pathogen-specific diseases. Synthetic Biologics, Inc. (NYSE MKT: SYN) is a microbiome-focused, clinical-stage company developing therapeutics to protect the microbiome while targeting pathogen-specific diseases. The Companys lead candidates in Phase 2 development include SYN-004 which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of. Aug 10, 2015. Aug 10, 2015. Jul 29, 2015.

http://www.syntheticbiologics.com/

OVERVIEW OF syntheticbiologics.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

6

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR SYNTHETICBIOLOGICS.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

February

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Monday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 4.1 out of 5 with 17 reviews

5 star

9

4 star

5

3 star

1

2 star

0

1 star

2

Hey there! Start your review of syntheticbiologics.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

0.7 seconds

FAVICON PREVIEW

16x16
32x32
64x64
128x128

CONTACTS AT SYNTHETICBIOLOGICS.COM

syntheticbiologics

Steve Kanzer

PO B●●●●1359

Sun●●●ale , CA, 94088

US

1.51●●●●2002

co●●●●●@myprivateregistration.com

View this contact

syntheticbiologics

Admin PrivateRegContact

PO Box 61359 r●●●●●●●●●●●●●● accepted only

Sun●●●ale , CA, 94088

US

1.51●●●●2002

co●●●●●@myprivateregistration.com

View this contact

Yahoo! Inc

TECH PrivateRegContact

PO Box 61359 r●●●●●●●●●●●●●● accepted only

Sun●●●ale , CA, 94088

US

1.51●●●●2002

co●●●●●@myprivateregistration.com

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 2011 December 06
UPDATED: 2013 December 06
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

12

YEARS
4

MONTHS
12

DAYS

NAME SERVERS

1: yns1.yahoo.com
2: yns2.yahoo.com

REGISTRAR

MELBOURNE IT, LTD. D/B/A INTERNET NAMES WORLDWIDE

WHOIS : whois.melbourneit.com

REFERRED : http://www.melbourneit.com

CONTENT

PAGES IN
THIS WEBSITE

6

SSL

EXTERNAL LINKS

13

SITE IP

64.78.159.10

LOAD TIME

0.703 sec

SCORE

6.2

PAGE TITLE

synthetic biologics - home | syntheticbiologics.com Reviews

<META> DESCRIPTION

Protecting the microbiome while targeting pathogen-specific diseases. Synthetic Biologics, Inc. (NYSE MKT: SYN) is a microbiome-focused, clinical-stage company developing therapeutics to protect the microbiome while targeting pathogen-specific diseases. The Companys lead candidates in Phase 2 development include SYN-004 which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of. Aug 10, 2015. Aug 10, 2015. Jul 29, 2015.

<META> KEYWORDS

1 synthetic biologics

2 microbiome

3 C. difficile

4 IBS

5 antibiotic-associated diarrhea

6 irritable bowel syndrome

7 constipation

8 gut microbiome

9 multiple sclerosis

10 pertussis

CONTENT

Page content here

KEYWORDS ON PAGE

about us,publications,product pipeline,investors,careers,social media,c difficile,recent press releases,videos,prevention of,infection,watch video,with constipation ibs c,events,in the news,business of bacteria,cnbc,md magazine,print,email

SERVER

Apache

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

synthetic biologics - home | syntheticbiologics.com Reviews

https://syntheticbiologics.com

Protecting the microbiome while targeting pathogen-specific diseases. Synthetic Biologics, Inc. (NYSE MKT: SYN) is a microbiome-focused, clinical-stage company developing therapeutics to protect the microbiome while targeting pathogen-specific diseases. The Companys lead candidates in Phase 2 development include SYN-004 which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of. Aug 10, 2015. Aug 10, 2015. Jul 29, 2015.

SUBDOMAINS

ir.syntheticbiologics.com

Investor Relations :: Synthetic Biologics, Inc. (SYN)

Jan 5, 2017. Synthetic Biologics' SYN-004 (ribaxamase) Achieves Primary Endpoint in Phase 2b Trial for C. difficile Infection (CDI). Sep 30, 2016. Sign Up for Email Alerts Sign Up Today. Our experienced management team holds an extensive clinical and commercial track record. View Board of Directors. Synthetic Biologics, Inc. Corporate Stock Transfer, Inc. 3200 Cherry Creek Drive South. Denver, CO 80209.

INTERNAL PAGES

syntheticbiologics.com

1

Synthetic Biologics, Inc. (SYN)

http://www.syntheticbiologics.com/index.php?s=134

Protecting the Gut Microbiome. Synthetic Biologics is developing cutting-edge therapeutics to treat pathogen-specific diseases. Our two leading candidates are:. SYN-004 (ribaxamase) to prevent. Infection and antibiotic-associated diarrhea. SYN-010 to treat irritable bowel syndrome with constipation (IBS-C). Our experienced management team has an extensive clinical and commercial track record. View Board of Directors. Aug 3, 2016 4:01pm EDT. Apr 19, 2016. View all in the news.

2

Scientific Publications :: Synthetic Biologics, Inc. (SYN)

http://www.syntheticbiologics.com/publications

Protection of the Gut Microbiome - Prevention of. Kokai-Kun JF et al. Nonclinical Safety Assessment of SYN-004: An Oral Beta-lactamase for the Protection of the Gut Microbiome From Disruption by Biliary-Excreted, Intravenously Administered Antibiotics. Int J Toxicol 2015 Dec 23. Crowther GS, Wilcox MH. Antibiotic therapy and Clostridium difficile infection-primum non nocere-first do no harm. Infection and drug resistance. 2015;8:333. Current Opinion in Investigational Drugs. 2009; 10(8):838-844. Stiefel ...

3

SYN-004 (ribaxamase) :: Synthetic Biologics, Inc. (SYN)

http://www.syntheticbiologics.com/SYN-004

Is the leading type of hospital acquired infection and is frequently associated with intravenous (IV) beta-lactam antibiotic treatment. Beta-lactam antibiotics are often the treatment of choice for hospitalized patients with infections; they include commonly used penicillin and cephalosporin antibiotics, such as ceftriaxone. However, antibiotics have the potential to cause harmful effects within the gastrointestinal (GI) tract including disruption of the natural balance of the gut microbiome, lea...SYN-0...

4

Synthetic Biologics, Inc. (SYN)

http://www.syntheticbiologics.com/index.php

Protecting the Gut Microbiome. Synthetic Biologics is developing cutting-edge therapeutics to treat pathogen-specific diseases. Our two leading candidates are:. SYN-004 (ribaxamase) to prevent. Infection and antibiotic-associated diarrhea. SYN-010 to treat irritable bowel syndrome with constipation (IBS-C). Our experienced management team has an extensive clinical and commercial track record. View Board of Directors. Aug 3, 2016 4:01pm EDT. Apr 19, 2016. View all in the news.

5

SYN-010 :: Synthetic Biologics, Inc. (SYN)

http://www.syntheticbiologics.com/SYN-010

SYN-010 is a proprietary, modified-release formulation of lovastatin lactone that is intended to reduce methane production by certain microorganisms (. In the gut while minimizing disruption to the microbiome to treat an underlying cause of irritable bowel syndrome with constipation (IBS-C). SYN-010 Treatment of IBS-C. Phase 1 Phase complete. Phase 2 Phase in progress. Phase 3 Phase not started. Market Phase not started. 4 Week Acute Study. The primary endpoint was the change from baseline in the area un...

UPGRADE TO PREMIUM TO VIEW 1 MORE

TOTAL PAGES IN THIS WEBSITE

6

LINKS TO THIS WEBSITE

pharmapositionveille.blogspot.com

Veille Pharma-Santé sur Internet: mars 2012

http://pharmapositionveille.blogspot.com/2012_03_01_archive.html

Veille Pharma-Santé sur Internet. Veille Stratégique sur Internet pour l'Industrie Pharmaceutique. Moteur de Recherche de Veille Concurrentielle pour l'Industrie Pharmaceutique et de Santé. Vidéo : Si cest écrit, cest vrai? France Brevets : fonds dinvestissement français s. Vidéo des États Généraux de lIntelligence Économi. Analyse mondiale de Thomson Reuters sur la proprié. Document de référence : Intelligence économique, c. Dernières Mises à jour de PharmaPosition.net, Mote. Jeudi 29 mars 2012. 24 juin...

microbiomeconference.com

More About the Microbiome and This Conference

http://www.microbiomeconference.com/index.php/2-uncategorised/9-more-about-the-microbiome-and-this-conference

April 11 - 13, 2017. Boston, MA USA. Translating the Microbiome From the Bench to Bedside: Challenges and Opportunities in Developing bioTherapeutics and Diagnostics. Last Year's Featured Speakers. Ananda Chakrabarty, Ph.D. Senior Science Mentor, Amrita Therapeutics. Matthew Steele, Ph.D. Primary Reviewer, US Food and Drug Administration. Dirk Gevers, Ph.D. Global Head Janssen Human Microbiome Institute, Janssen Research and Development. Tweets by @microbiome news. Diams; Skin Microbiome. First, this yea...

microbiomecongress.com

Sponsors - The Microbiome Congress – Europe – Kisaco Research

http://microbiomecongress.com/2016-event-sponsor

Sponsors - The Microbiome Congress Europe Kisaco Research. Next event just announced! More details to come. 28-30 November, 2017 / London, UK. Present a Poster Session. Why Attend the Microbiome Congress? Microbiome in the News. Venue & Accommodations. Sign Up for Our Free Newsletter. Contact the Microbiome Congress team. Http:/ www.bioqubeventures.com/. The Janssen Human Microbiome Institute. Http:/ www.janssen.com/human-microbiome-institute. Http:/ www.baseclear.com. Accelerate and transform your resea...

cosmosid.com

The importance of Antibiotic Stewardship — CosmosID - Exploring the Universe of Microbes

http://www.cosmosid.com/blog-cosmosid/antibiotic-stewardship

July 7, 2015. The importance of Antibiotic Stewardship. July 7, 2015. For 2016, President Obama has requested more than $1.2B to fight antibiotic resistance. The main goal. Of this antibiotic stewardship. Program is to slow the emergence of resistant bacteria and prevent the spread of resistant infections . Even today, this problem is critical, as The Centers for Disease Control and Prevention ( CDC. Http:/ www.statista.com/chart/3095/drug-resistant-infections/. A complication of infection that can lead ...

ir.syntheticbiologics.com

Synthetic Biologics Reports Third Quarter 2016 Operational Highlights and Financial Results :: Synthetic Biologics, Inc. (SYN)

http://ir.syntheticbiologics.com/press-releases/detail/223

Synthetic Biologics Reports Third Quarter 2016 Operational Highlights and Financial Results. November 01, 2016. Completed Enrollment of Phase 2b Proof-of-Concept Clinical Trial for the Prevention of C. difficile Infection (CDI), Antibiotic-Associated Diarrhea (AAD) and the Emergence of Antibiotic-Resistant Organisms -. Awarded Research Contract from Centers for Disease Control and Prevention to Determine SYN-004's (ribaxamase) Ability to Prevent Antibiotic-Resistance in the Gut Microbiome -. Awarded gove...

emvereniging.nl

Probiotica | EM VERENIGING NEDERLAND

http://www.emvereniging.nl/category/probiotica

Speciale jubileumuitgave van Agriton: Fermenteren. Speciaal voor hun 25 jarig bestaan heeft Agriton een cadeau voor alle EM en fermentatie fans samengesteld: de jubileum uitgave van Agriton: Fermenteren. Wat is eigenlijk fermenteren? En waarom in de bodem? Download de PDF hier. Of bekijk hem hieronder:. EM Natuurlijk Actief Nieuws. Huis en Tuin toepassingen. Waar kan ik EM producten kopen? Onderzoek naar bacteriën bij niet-vleeseters. Om hier achter te komen zoekt het Rijksinstituut voor Volksgezondheid ...

cdifffoundation.org

♦ Previous Events ♦ | C Diff Foundation

https://cdifffoundation.org/upcoming-events

C diff. — Educating and Advocating for the Prevention, Treatment and Environmental Safety of Clostridium Difficile Infections Worldwide. C diff. Survivors Alliance Network. What is C. diff. (Clostridium difficile)? C diff. Radio AND Podcasts. Cdiff Support Listings and Register Here. Clinical Studies In Progress To Help You. Hand Washing and Updates. C diff. In Schools A Guide For School Nurses. Support Our Mission Donation Page. Overview 4th Annual Conference. Awareness Conference and Health EXPO. Is an...

thirdsecurity.com

Third Security: Affiliated Investment Funds

http://www.thirdsecurity.com/aif

New River Management Funds:. The following constitute our New River Management Funds:. New River Management Company, L.L.C. (1996-2002). New River Management II, LP (2003-2012). New River Management III, LP (2004-2011). New River Management IV, LP (Launched 2006). New River Management V, LP (Launched 2007). New River Management VI, (Launched 2009). New River Management VII, LP (Launched 2012). NewVa Capital Partners, LP(2004-2014). Valleys' Ventures, LP (Launched 2013). The objective of Valleys' Ventures...

UPGRADE TO PREMIUM TO VIEW 5 MORE

TOTAL LINKS TO THIS WEBSITE

13

OTHER SITES

syntheticbiocompany.com

syntheticbiocompany.com - This website is for sale! - biotechnology synthetic cell health Resources and Information.

The owner of syntheticbiocompany.com. Is offering it for sale for an asking price of 10000 USD! This page provided to the domain owner free. By Sedo's Domain Parking. Disclaimer: Domain owner and Sedo maintain no relationship with third party advertisers. Reference to any specific service or trade mark is not controlled by Sedo or domain owner and does not constitute or imply its association, endorsement or recommendation.

syntheticbiocorporation.com

syntheticbiocorporation.com - This website is for sale! - biotechnology synthetic cell health Resources and Information.

The owner of syntheticbiocorporation.com. Is offering it for sale for an asking price of 10000 USD! This page provided to the domain owner free. By Sedo's Domain Parking. Disclaimer: Domain owner and Sedo maintain no relationship with third party advertisers. Reference to any specific service or trade mark is not controlled by Sedo or domain owner and does not constitute or imply its association, endorsement or recommendation.

syntheticbiofuel.com

Synthetic Biology News - SynBiology.co.uk

Health & Medicine. Self-Destructing Genes Herald New Advances in Gene Therapy. At the University of Texas, a new gene therapy system has been developed using methods rooted in synthetic biology. Bioengineers at the …. February 17, 2015. Redesigning plants for drought tolerance. The University of California - Riverside stated that plants produce abscisic acid (ABA) when they face drought-like conditions. Abscisic …. February 7, 2015. Engineering a new class of BioSensors. January 13, 2015. January 10, 2015.

syntheticbiofuels.us

syntheticbiofuels.us - Under Construction

This Domain is Under Construction. Please Check Back Later.

syntheticbiogroup.com

syntheticbiogroup.com - This website is for sale! - biotechnology synthetic cell health Resources and Information.

The owner of syntheticbiogroup.com. Is offering it for sale for an asking price of 10000 USD! This page provided to the domain owner free. By Sedo's Domain Parking. Disclaimer: Domain owner and Sedo maintain no relationship with third party advertisers. Reference to any specific service or trade mark is not controlled by Sedo or domain owner and does not constitute or imply its association, endorsement or recommendation.

syntheticbiologics.com

synthetic biologics - home

Protecting the microbiome while targeting pathogen-specific diseases. Synthetic Biologics, Inc. (NYSE MKT: SYN) is a microbiome-focused, clinical-stage company developing therapeutics to protect the microbiome while targeting pathogen-specific diseases. The Companys lead candidates in Phase 2 development include SYN-004 which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of. Aug 10, 2015. Aug 10, 2015. Jul 29, 2015.

syntheticbiology.com

Synthetic Biology

syntheticbiology.northwestern.edu

Center for Synthetic Biology - Northwestern University

Skip to main content. Ethics and Societal Impact. Learn about the areas of research focus at the Center. Ethics and Societal Impact. Meet people from three Northwestern schools associated with the Center. The Center engages students through courses, research activities, and student groups. Go to Contact Us. Center for Synthetic Biology. Programming Biological Systems to Solve Big Problems. What is Synthetic Biology? The Center's research spans four unique themes:. Ethics and Societal Impact. In order to ...

syntheticbiology.or.kr

KAIST bio design

연구성과 평가 및 평가지표. 신규과제] 지능형 바이오시스템 설계 및. 연구단 연구원 채용 입사지원서. 재)바이오합성연구단 연구원 상시채용 . 미생물을 이용한 이타콘산 생산 및 동향. Whole-Genome and Whole-Population 분석. 세균의 번역 스트레스 반응. 성장과 복지를 위한 바이오 미래전략. 미래창조과학부, 2014년도 예산 13조 5,7. 305-701 대전시 유성구 대학로 291 한국과학기술원 KI빌딩 4층 TEL. 042-350-8722 4 FAX. 042-350-8720.

syntheticbiology.org

Synthetic Biology

A) the design and construction of new biological parts, devices, and systems, and. B) the re-design of existing, natural biological systems for useful purposes. SynBioBeta San Francisco 2015. San Francisco, Mission Bay Conference Center, November 4 - 6 2015. London, April 22 - 23 2015. International Synthetic and Systems Biology Summer School. Taormina, Italy, 5 - 9 July 2015. First lab manual for SynBio published Synthetic Biology: A Lab Manual. Singapore, June 16th 2014. New Courses in Synthetic Biology.

syntheticbiology.us

Welcome to SyntheticBiology.us